COMMUNIQUÉS West-GlobeNewswire

“He’s No Prince” PSA Shatters Fairy Tale Illusions to Expose Emotional Abuse
04/09/2025
Safe in Harm’s Way and Neon, an IPG Health company, Unveil Final Installment in Award-Winning Domestic Violence Billboard Series NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- What if Prince Charming wasn’t so charming [...]
VIVUS Showcases Leadership in Obesity Management at the 2025 International Congress on Obesity and MEtabolic Syndrome (ICOMES)
04/09/2025
— Presentations spotlight VIVUS’s 13-year track record of leadership with QSYMIA® (phentermine and topiramate extended-release capsules CIV) in the treatment of obesity and overweight CAMPBELL, Calif., Sept. 04, 2025 ( [...]
Raleigh Orthopaedic Implements Full Athelas Product Suite to Enhance Workflow Efficiency and Patient Care
04/09/2025
Athelas products will help Raleigh Orthopaedic streamline clinical and administrative tasks, giving clinicians more time to spend on patient care MOUNTAIN VIEW, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Athelas , a [...]
Mark Mikhael, CEO of Olympia and Wesley Pharmaceuticals, Named Pharmacist of the Year by the Florida Society of Health-System Pharmacists
04/09/2025
The prestigious honor recognizes Mikhael’s exceptional leadership, commitment to advancing patient care, and significant contributions to the pharmaceutical industry across Florida ORLANDO, Fla., Sept. 04, 2025 (GLOBE [...]
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment
04/09/2025
Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses the Company’s recently announced results from the post hoc analysis of its proof-of-concept human clinical trial (“PoC 1”) THE WOODLANDS, TX, Sept. 04, [...]
BioCardia CEO Peter Altman to Present at the H. C. Wainwright 27th Annual Global Investment Conference in New York City September 8-10, 2025
04/09/2025
SUNNYVALE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- - BioCardia ® , Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces [...]
Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients
04/09/2025
Collaboration builds upon positive results utilizing Predictive Oncology’s AI platform to identify new indications for existing drugs PITTSBURGH, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI [...]
Hydreight Announces Closing of its Oversubscribed $11.5 Million Convertible Debenture Offering, Including Full Exercise of Over-Allotment Option
04/09/2025
VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), a leader in nationwide digital healthcare solutions, is [...]
Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
04/09/2025
REYKJAVIK, Iceland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today [...]
Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
04/09/2025
REYKJAVIK, Iceland, June 4, 2025 - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in [...]
Vireo Growth Inc. Comments on Recent Market Activity; Company Unaware of Any Material Change
04/09/2025
MINNEAPOLIS , Sept. 04, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), at the request of the Canadian Investment Regulatory Organization (“CIRO”), today confirmed that [...]
Silexion Therapeutics Announces Selection of Contract Research Organization to Support Upcoming Phase 2/3 Clinical Trials for SIL204
04/09/2025
Strategic CRO to Support Path to Phase 2/3 Trials Following Recently Demonstrated Groundbreaking 97% Inhibition Rates for SIL204 Phase 2/3 Clinical Trials Expected to Commence in First Half of 2026 Following Q4 2025 and [...]
Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina
04/09/2025
LAS VEGAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, [...]
The University of Alabama and GATC Health Unveil Strategic Program to Accelerate Therapeutic Discovery and Development
04/09/2025
Combining university-led scientific research with advanced AI technology, this innovative model accelerates the transformation of academic research into commercially viable therapies IRVINE, Calif., Sept. 04, 2025 ( [...]
Really Global Launches Global Mental Health Marketplace with 2000+ Search Filters Connecting Clients to Providers in 200+ Countries
04/09/2025
Direct-pay platform eliminates insurance barriers while offering unprecedented search precision for trauma, ADHD, anxiety, and specialty care San Francisco, CA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Really Global today [...]
Rakovina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
04/09/2025
VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI- [...]
ITM to Present at the Oppenheimer Annual Targeted Radiopharmaceutical Therapies in Oncology Summit
04/09/2025
Garching / Munich, Germany, September 4, 2025 – ITM Isotope Technologies Munich SE (ITM) , a leading radiopharmaceutical biotech company, today announced its participation in the Oppenheimer Annual Targeted [...]
ALK expands the Executive Leadership Team to include key commercial regions
04/09/2025
ALK (ALKB:DC / OMX: ALK B) today announced the decision to elevate its key commercial regions into the Executive Leadership Team (ELT) to further strengthen the execution of ALK’s strategy, Allergy+ . Effective as of 1 [...]
BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
04/09/2025
NEW HAVEN, Conn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today [...]

Pages